Utah AI Healthcare Sandbox Third Wave — Drug Management, Women's Health, and Third-Party Auditing
OVERVIEWUtah's pioneering AI healthcare regulatory sandbox is entering a third wave of expansion, moving beyond initial autonomous prescribing pilots into drug management systems and women's health applications. The state is also introducing third-party evaluation and auditing frameworks to assess AI system safety and clinical utility before broader deployment. The expanded sandbox now includes pilots on AI-assisted drug management protocols and women's health screening systems, with external auditors tasked with evaluating whether these autonomous or semi-autonomous systems meet clinical and safety thresholds. This represents a shift from pure innovation space toward structured post-pilot assessment—acknowledging that sandboxes require exit criteria and independent validation. Utah's model is being watched nationally as states consider how to balance AI innovation incentives with accountability mechanisms. The introduction of third-party auditors suggests growing recognition that state-level AI healthcare governance cannot rely on vendor self-reporting alone. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.